Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 62 63 64 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Addex Therapeutics S.A.. (1/29/13). "Press Release: Addex Dipraglurant Reduces Motor Abnormalities in a Preclinical Model Relevant for Several Rare Types of Dystonia". Geneva. 2013-01-29
AiCuris GmbH & Co. KG. (1/29/13). "Press Release: AiCuris Surpasses 50% Enrollment Milestone in Phase II Superiority Trial for Herpes Drug Pritelivir". Wuppertal. 2013-01-29
Barmer GEK. (1/29/13). "Pressemitteilung: Barmer GEK Arztreport 2013. ADHS-Diagnosen und Ritalin-Verordnungen boomen". Berlin. 2013-01-29
BASF SE. (1/29/13). "Press Release: BASF to Expand Its Plant Biotechnology Research into Fungal Resistance in Corn". Research Triangle Park, NC. 2013-01-29
Zytoprotec GmbH. (1/29/13). "Press Release: Zytoprotec Raises EUR 2 Million in Financing from Baxter Ventures". Vienna. 2013-01-29
High-Tech Gründerfonds Management GmbH. (1/28/13). "Press Release: HTGF, BayernKapital and a Business Angel Consortium Invest in Advanova GmbH". Bonn, Landshut & Erlangen. 2013-01-28
Epigenomics AG. (1/25/13). "Press Release: Epigenomics AG Successfully Completes Capital Increase [Not for distribution in the United States]". Berlin & Seattle, WA. 2013-01-25
Lead Discovery Center GmbH. (1/25/13). "Press Release: LDC Forms Drug Discovery Alliance with AstraZeneca". Dortmund. 2013-01-25
Biognosys AG. (1/23/13). "Press Release: Biognosys Announces Spectronaut Software Launch". Zürich-Schlieren. 2013-01-23
Merck Serono. (1/23/13). "Press Release: Merck Serono Announces the Creation of Ondaco, the Fifth Company Stemming From Its Entrepreneur Partnership Program". Geneva. 2013-01-23
Apoplex Medical Technologies GmbH. (1/23/13). "Pressemitteilung: Gut für Herz und Hirn – Kooperation entlastet Klinikpersonal und Schlaganfallpatienten. Dräger und Apoplex Medical Technologies kombinieren Technologien". Pirmasens. 2013-01-23
Bayer AG. (1/23/13). "Press Release: Dr. Jörg Reinhardt to Leave Bayer HealthCare". Leverkusen. 2013-01-23
BMBF. (1/23/13). "Pressemitteilung: Die Vermessung der Pflanze. Deutsches Pflanzen-Phänotypisierungs-Netzwerk geht an den Start – Rachel: »Erträge von Nutzpflanzen müssen gesteigert werden". 2013-01-23
Cytos Biotechnology AG. (1/23/13). "Press Release: Cytos to Regain Rights to Smoking Cessation Vaccine". Schlieren. 2013-01-23
Addex Therapeutics S.A.. (1/22/13). "Press Release: Addex Announces Issuance of a Broad US Composition of Matter Patent for ADX71441". Geneva. 2013-01-22
Lophius Biosciences GmbH. (1/22/13). "Press Release: Lophius Biosciences Closes Financing Round and Expands Management Board. Financing Round Closed with Volume of about 4 Mio. EUR". Regensburg. 2013-01-22
Deutsche Metrohm GmbH & Co. KG. (1/22/13). "Pressemitteilung: Neue Geschäftsleitungen bei Methrom Deutschland". 2013-01-22
Biotest AG. (1/22/13). "Press Release: Ad hoc. Biotest AG – Increase in Earnings after Tax for Fiscal Year 2012". Dreieich. 2013-01-22
Novartis AG. (1/22/13). "Press Release: Novartis Receives EU Approval for Bexsero, First Vaccine to Prevent the Leading Cause of Life-threatening Meningitits across Europe". Basel. 2013-01-22
BioRegio STERN Management GmbH. (1/21/13). "Pressemitteilung: Reduktion von Tierversuchen durch neue in vivo-Biomaterialtests. NMI entwickelt Mikrosensorimplantat zur Überwachung implantierbarer Biomaterialien". 2013-01-21
Biotest AG. (1/21/13). "Press Release: Biotest AG with New Sales and Distribution Activities in Russia and Greece". Dreieich. 2013-01-21
Centre for Drug Research and Development, The (CDRD). (1/21/13). "Press Release: Alliance of Translational Research Centres Established to Accelerate Global Drug Development". London & Vancouver, BC. 2013-01-21
Schott North America. (1/21/13). "Press Release: Schott and Applied Microarrays Establish Distribution Partnership for Nexterion Products in the US and Canada". Elmsford, NY & Tempe, AZ. 2013-01-21
ETH Zürich. (1/21/13). "Pressemitteilung: Exakte Karte für das Hefe-Proteom". 2013-01-21
Bayer AG. (1/21/13). "Press Release: Further Milestone Towards Building a Leading Biologics Technology Platform. Bayer CropScience Completes Acquisition of Prophyta GmbH". Monheim. 2013-01-21
Ayoxxa Biosystems GmbH. (1/21/13). "Press Release: Ayoxxa Biosystems Announces Signing of a Research Collaboration Agreement with the National University of Singapore as well as a Second Closing of the Series A Financing Round". Singapore & Cologne. 2013-01-21
Apeptico Forschung und Entwicklung GmbH. (1/18/13). "Press Release: Apeptico Granted Orphan Drug Designation by EMA and FDA for Development Compound AP301 for Treatment of High Altitude Pulmonary Oedema". Vienna. 2013-01-18
Bruker Corporation. (1/18/13). "Press Release: Bruker Wins Order from Former IUCr President. D8 Venture SC-XRD System for Charge Density and Protein Structure Investigations". 2013-01-18
BioRegio STERN Management GmbH. (1/17/13). "Pressemitteilung: »Wir machen Unsichtbares sichtbar«. Tübinger Start-up hat sich auf die genomische Analyse von Saatgut spezialisiert". 2013-01-17
Biotest AG. (1/16/13). "Press Release: Biotest Announces Strategic Long-term Manufacturing, Supply and License Agreement". Dreieich & Baco Raton, FL. 2013-01-16
Markes International Ltd.. (1/16/13). "Press Release: Business as Usual for Markes International as Schauenburg International Acquires a Majority Share". Llantrisant. 2013-01-16
Paladin Labs, Inc.. (1/16/13). "Press Release: Paladin Labs Signs Agreement for Novel Biologic to Treat Neuroblastoma". Montréal, QC. 2013-01-16
Almsco International. (1/16/13). "Press Release: Almsco at Pittcon 2013. Cutting-edge Mass Spectrometry Technology on Show at Pittcon 2013". 2013-01-16
BB Biotech AG. (1/16/13). "Press Release: BB Biotech AG Earns After-tax Profits of CHF 368 Million in Fiscal 2012". 2013-01-16
Cytos Biotechnology AG. (1/16/13). "Press Release: Cytos Provides Update of Phase 2b Clinical Trial of CYT003 in Allergic Asthma. Guidance for Top-line Results in 1H 2014 Reiterated". Schlieren. 2013-01-16
Biocartis S.A.. (1/15/13). "Press Release: Biocartis Strengthens Management Team with General Counsel". Lausanne & Mechelen. 2013-01-15
IBB Netzwerk GmbH. (1/15/13). "Press Release: Launch of New Website Completes Change of Name of Industrielle Biotechnologie Bayern Netzwerk GmbH". Martinsried. 2013-01-15
Omnilab-Laborzentrum GmbH & Co. KG. (1/15/13). "Pressemitteilung: Omnilab und Bruker gehen gemeinsame Vertriebswege. Mit Beginn 2013 neue Kooperation der beiden Firmen". 2013-01-15
John Wiley & Sons, Inc.. (1/15/13). "Press Release: Wiley Acquires Assets of FIZ Chemie Berlin. Extended and Integrated Portfolio Will Support Development of New Services for Chemists". Hoboken, NJ. 2013-01-15
BASF SE. (1/15/13). "Press Release: BASF Increases Cash Offer for Pronova BioPharma. Cash Offer Increased to NOK 13.50 per Share". Ludwigshafen. 2013-01-15
BIO Deutschland. (1/14/13). "Press Release: The Atmosphere in the Biotech Sector Remains Positive although Expectations Are Lower than Before. The Willingness to invest Has Reached a New High". Berlin. 2013-01-14
Horizon Discovery Ltd.. (1/14/13). "Press Release: Horizon Discovery and Boehringer Ingelheim Enter Oncology Research Service Collaboration. Five Year Collaboration Will Support Boehringer Ingelheim’s Drug Discovery Programs". Cambridge, UK. 2013-01-14
Universität Göttingen. (1/11/13). "Pressemitteilung: Norddeutsches Zentrum für Mikrobielle Genomforschung eröffnet. Sechs Forschungseinrichtungen kooperieren in den Lebenswissenschaften". 2013-01-11
Almsco International. (1/11/13). "Press Release: New Almsco International Website. New GC/TOF-related Website Offers Analytical Chemists a Wealth of Information". Llantrisant. 2013-01-11
TÜV Süd AG. (1/11/13). "Press Release: TÜV Süd Acquires Food Laboratory in Italy". 2013-01-11
Bavarian Nordic A/S. (1/11/13). "Press Release: Bavarian Nordic Consolidates Its Vaccine Manufacturing in Denmark". Kvistgaard. 2013-01-11
Bayer AG. (1/10/13). "Press Release: Bayer Receives Approval for New Long-term Contraceptive Skyla in the U.S.. New Low Dose Levonorgestrel-releasing Intrauterine System (IUS) – Longterm Contraception for Up to Three Years [Not intended for U.S. and UK m 2013-01-10
Proteo Biotech AG. (1/10/13). "Press Release: FDA Grants Proteo Orphan Drug Designation to Elafin for the Treatment of Pulmonary Arterial Hypertension". Irvine, CA & Kiel. 2013-01-10
Evotec AG. (1/9/13). "Press Release: Evotec and Yale University Form Open Innovation Alliance". Hamburg. 2013-01-09
SIRS-Lab GmbH / Leonhardt Rechtsanwälkte Insolvenzverwalter Notare. (1/9/13). "Press Release: Investor Search for Molecular Diagnostics Company Started. Diagnostics Company SIRS-Lab Insolvent". Jena. 2013-01-09
Biotest AG. (1/9/13). "Press Release: Biotest AG’s Supervisory Board Extends the Term of CEO Prof. Schulz and Appoints Dr. Floß to the Board of Management". Dreieich. 2013-01-09
Biomax Informatics AG. (1/9/13). "Press Release: Biomax Informatics Provides Knowledge Management and Semantic Software Technology, with European STATegra Project, Enabling Integrated Biological Systems Analysis". Planegg. 2013-01-09
Debiopharm S.A.. (1/9/13). "Press Release: Spinomix Closes a $ 3 Million Financing Round Led by Debiopharm Group". Lausanne. 2013-01-09
4SC AG. (1/8/13). "Press Release: 4SC Obtains Key Patent for Anti-cancer Compound Resminostat in Europe". Planegg-Martinsried. 2013-01-08
Lonza Group Ltd.. (1/8/13). "Press Release: Lonza to Expand Antibody Drug Conjugate (ADC) Manufacturing Capacity to Meet Growing Customer Demand". Basel. 2013-01-08
CLC bio A/S. (1/8/13). "Press Release: J. Craig Venter Institute Extends CLC bio Site License through 2017". Aarhus. 2013-01-08
Bayer AG. (1/8/13). "Press Release: Bayer CropScience Acquires Germany-based Biocontrol Company Prophyta GmbH". Monheim. 2013-01-08
Debiopharm S.A.. (1/8/13). "Press Release: Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-cancer Agent FF284 (Debio 1347)". Lausanne & Tokyo. 2013-01-08
Formycon AG. (1/8/13). "Press Release: Formycon AG Begins Development of First Biosimilar Drug". Munich. 2013-01-08
Miltenyi Biotec GmbH. (1/7/13). "Press Release: Miltenyi Biotec Distributes and Supports FlowJo 10 Software in Europe". Bergisch Gladbach. 2013-01-07
Cell Signaling Technology, Inc.. (1/7/13). "Press Release: Cell Signaling Technology Granted Patent for PCR Methods for Detection of a Subset of Treatable Non-small Cell Lung Cancers". Danvers, MA. 2013-01-07
Ethris GmbH. (1/7/13). "Press Release: Ethris Announces Research Based Alliance on SNIM Modified RNA with Shire". Munich. 2013-01-07
Evotec AG. (1/7/13). "Press Release: Evotec Expands Collaboration with MedImmune, Receives Milestone Payment". Hamburg. 2013-01-07
High-Tech Gründerfonds Management GmbH. (1/7/13). "Press Release: Drug Response Dx Concludes First Round of Financing with Support from Qiagen and High-Tech Gründerfonds". Hennigsdorf, Bonn & Hilden. 2013-01-07
Priaxon AG. (1/7/13). "Press Release: Priaxon Enters Collaboration with GSK on Protein-Protein-Interactions". Munich. 2013-01-07
Qiagen N.V.. (1/7/13). "Press Release: Qiagen Adds to Pipeline of Personalized Healthcare Diagnostics through Agreements for Promising New Biomarkers". Hilden & Germantown, MD. 2013-01-07
Epizyme, Inc.. (1/7/13). "Press Release: Epizyme, Eisai and Roche to Develop EZH2 Companion Diagnostic. Collaboration Focused on Genetically Defined Lymphomas". Cambridge, MA. 2013-01-07
Addex Therapeutics S.A.. (1/7/13). "Press Release: Addex Announces Positive Data with ADX71441 in a Pre-clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease". Geneva. 2013-01-07
Bayer AG. (1/7/13). "Press Release: Bayer Submits VEGF Trap-eye (aflibercept) for Treatment of Macular Edema Following Central Retinal Vein Occlusion in Japan". Berlin. 2013-01-07
Boehringer Ingelheim. (1/7/13). "Press Release: Boehringer Ingelheim and Eli Lilly and Company Announce Positive Top-line Pivotal Phase III Data Results for Empagliflozin [Ex US & UK Medical Media Only]". Ingelheim. 2013-01-07
Boehringer Ingelheim. (1/7/13). "Press Release: Lilly Reassumes Sole Worldwide Development and Commercialization Rights for Novel Basal Insulin Analog. Announces It Will Begin Remainder of Pre-planned Clinical Trials for LY2605541". Indianapolis, IN & In 2013-01-07
Bayer AG. (1/4/13). "Press Release: Bayer HealthCare Completes Acquisition of Teva’s U.S. Animal Health Business [Not intended for U.S. media]". Leverkusen. 2013-01-04
Bruker Corporation. (1/3/13). "Press Release: Bruker and Erasmus Medical Center Sign an Exclusive Licensing Agreement for Adding Rapid Beta-Lactamase Testing Capabilities to the MALDI Biotyper System". Bremen. 2013-01-03
Cevec Pharmaceuticals GmbH. (1/3/13). "Press Release: Cevec Pharmaceuticals and Vakzine Projekt Management Sign Exclusive License Agreement on the Clinical Development of a Novel Human Cytomegalovirus (CMV) Vaccine". Cologne. 2013-01-03
Evotec AG. (1/3/13). "Press Release: Evotec Acquires Cell Culture Service GmbH. Strenghtens Cell-based Screening and Reagent Platform at Evotec’s Hamburg Site". Hamburg. 2013-01-03
Pfizer Inc.. (1/3/13). "Press Release: EMD Serono and Pfizer Announce FDA Approval of Rebif Rebidose (interferon beta-1a). The Majority of Patients Found Rebif Rebidose Easy to Use in a User Trial". Rockland, MA & New York, NY. 2013-01-03
Zellkraftwerk. (1/3/13). "Press Release: Zellkraftwerk Announces Early Access Program. Select Drug Developers to Obtain Pre-release Access to Groundbreaking Cellular Biomarker Discovery Platform". Hannover. 2013-01-03
Bayer AG. (1/3/13). "Press Release: Phase III DECISION Trial of Nexavar (sorafenib) Meets Primary Endpoint of Improving Progression-free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer [Not intended for U.S. and UK m 2013-01-03
Miltenyi Biotec GmbH. (1/3/13). "Press Release: Nordic Working – the New Miltenyi Biotec Team in Lund, Sweden". Bergisch Gladbach. 2013-01-03
Evotec AG. (1/2/13). "Press Release: Evotec and Apeiron Biologics Announce Collaboration on Cancer Immunotherapy". Hamburg. 2013-01-02
Sphingotec GmbH. (1/2/13). "Press Release: Sphingotec Announces Launch of Blood Test for Breast Cancer Prediciton. Proneurotensin (pro-NT) Is a Unique Biomarker for Breast Cancer Prediction in Women". Hennigsdorf. 2013-01-02
Abbott. (1/2/13). "Press Release: Abbott Completes Separation of Research-based Pharmaceuticals Business". Abbott Park, IL. 2013-01-02
Lonza Group Ltd.. (12/28/12). "Press Release: Lonza Completes the Divestiture of Its Brandenburg, KY Performance Urethanes and Organics Business to Monument Chemical". Basel & Indianapolis, IN. 2012-12-28
Epigenomics AG. (12/21/12). "Press Release: Epigenomics AG. Notice of Loss Pursuant to § 92 par. 1 AktG (Ad hoc release) [Not for distribution in the United States]". Berlin. 2012-12-21
Novartis AG. (12/21/12). "Press Release: Novartis Drug Exjade Approved by European Commission for Iron Overload in Patients with Non-transfusion-dependent Thalassemia". Basel. 2012-12-21
Octpaharma AG. (12/21/12). "Press Release: Octapharma Wins Major Tender Victory in Norway". Lachen. 2012-12-21
Sanochemia Pharmazeutika AG. (12/21/12). "Pressemitteilung: Vorläufige Zahlen für das Geschäftsjahr 2011/12". Wien. 2012-12-21
Sanochemia Pharmazeutika AG. (12/21/12). "Pressemitteilung: Änderungen in der Geschäftsführung der Sanochemia Pharmazeutika AG". Wien. 2012-12-21
Cevec Pharmaceuticals GmbH. (12/20/12). "Press Release: Cevec Pharmaceuticals Signs License Agreement with Yuhan Corporation". Cologne. 2012-12-20
Biotest AG. (12/20/12). "Press Release: FDA Approves Biotest’s Bivigam, an Intravenous Immune Globulin (Human), 10% Liquid". Dreieich & Baco Raton, FL. 2012-12-20
Epigenomics AG. (12/20/12). "Press Release: Epigenomics AG Provides Update on Financing Plan [Not for distribution in the United States]". Berlin & Seattle, WA. 2012-12-20
Galenica Holding AG. (12/20/12). "Press Release: PA21 Dossier Sent for Submission to EMA to Seek Approval in the EU". 2012-12-20
Sygnis Pharma AG. (12/20/12). "Press Release: Sygnis Announces the Adaptation of Its Organisation to the New Business Activity". Heidelberg. 2012-12-20
Addex Therapeutics S.A.. (12/20/12). "Press Release: Addex Scientists Discover and Characterize the First Potent and Selective Small Molecule Negative Allosteric Modulator Targeting mGlu7 Receptor". Geneva. 2012-12-20
Evolva Holding S.A.. (12/20/12). "Press Release: Evolva Successfully Discussed Clinical Development Plans for EV-077 in Diabetes Patients with German Regulatory Authority". Reinach. 2012-12-20
Epigenomics AG. (12/19/12). "Press Release: Epigenomics Provides Additional Data of Its Head-to-Head Comparison Study of Epi proColon to FIT". Berlin & Seattle, WA. 2012-12-19
Intercell AG. (12/19/12). "Press Release: Intercell Receives CHMP Positive Opinion for the Pediatric Indication of Its Japanese Encephalitis Vaccine in Europe". Vienna. 2012-12-19
Lonza Group Ltd.. (12/19/12). "Press Release: Lonza and Sartorius Stedim Biotech Enter Collaboration, Supply and Distribution Agreement in the Field of Cell Culture Media". Basel. 2012-12-19
Analytik Jena AG. (12/18/12). "Press Release: Group Figures for the 2011/2012 Financial Year. Analytik Jena Exceeds Forecasts and Confirms Preliminary Figures". Jena. 2012-12-18
Sartorius Stedim Biotech GmbH. (12/18/12). "Press Release: Sartorius Stedim Biotech Expands PAT Software Portfolio for Optimization of Biopharmaceutical Development and Manufacturing Processes". Göttingen. 2012-12-18
next pagenext page 1 2 3 ... 62 63 64 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top